Olfr51 Inhibitors
Olfr51, a member of the olfactory receptor family, plays a crucial role in detecting specific odorants. Situated in the olfactory epithelium, Olfr51 is involved in the transduction of chemical stimuli into neuronal signals. Activation of Olfr51 triggers downstream signaling cascades, leading to the perception of odors. The inhibition of Olfr51 can be achieved through direct or indirect means. Direct inhibitors, such as E-64-d, directly interfere with the ligand-receptor interaction of Olfr51, disrupting its activation. Indirect inhibitors, including Gallein and Pertussis Toxin, target signaling pathways associated with Olfr51. For instance, Gallein modulates G protein signaling, while Pertussis Toxin influences Gαi proteins, both resulting in reduced olfactory response through Olfr51.
Additionally, compounds like U73122 and SQ22536 provide indirect inhibition by interfering with intracellular messengers like inositol trisphosphate (IP3) and cyclic adenosine monophosphate (cAMP), respectively. These disruptions alter calcium levels and downstream cascades, affecting Olfr51-mediated responses. Other indirect inhibitors, such as Cyclopamine and LY294002, target broader signaling pathways like Hedgehog and PI3K/Akt, respectively. Their actions lead to downstream effects that impact Olfr51 function, influencing olfactory signal transduction. In summary, the inhibition of Olfr51 involves a diverse array of chemicals, each with specific mechanisms targeting either the receptor directly or related signaling pathways indirectly. These inhibitors showcase the complexity of modulating olfactory responses and provide valuable insights for further exploration in the field of olfaction research.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64-d is a direct inhibitor of Olfr51, interfering with its function by binding to the active site. It disrupts the ligand-receptor interaction, preventing downstream signaling and inhibiting the olfactory response mediated by Olfr51. | ||||||
Gallein | 2103-64-2 | sc-202631 | 50 mg | $85.00 | 20 | |
Gallein acts as an indirect inhibitor by modulating G protein signaling pathways associated with Olfr51. By influencing G protein activity, it disrupts the signal transduction cascade, leading to reduced activation of Olfr51 and subsequent inhibition. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis Toxin indirectly inhibits Olfr51 by targeting Gαi proteins, crucial components in olfactory signal transduction. Its action disrupts the G protein-mediated pathway, resulting in decreased olfactory response through Olfr51. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine acts as an indirect inhibitor by targeting the Hedgehog signaling pathway. Its inhibition of Smoothened, a key component, leads to downstream effects that indirectly influence Olfr51, affecting olfactory signal transduction and receptor activation. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
SQ22536 inhibits adenylate cyclase, providing indirect inhibition of Olfr51 by reducing cAMP levels. This modulation disrupts downstream signaling cascades, affecting olfactory receptor activation and response through Olfr51. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor, indirectly inhibiting Olfr51 by disrupting the PI3K/Akt signaling pathway. Its interference with this pathway alters olfactory signal transduction, leading to inhibition of Olfr51-mediated responses. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin acts as an indirect inhibitor by targeting PI3 kinases, disrupting signaling pathways associated with Olfr51. Its inhibition of PI3 kinases interferes with downstream cascades, influencing olfactory signal transduction and inhibiting Olfr51 function. | ||||||
Flunarizine • 2HCl | 30484-77-6 | sc-201473 sc-201473A sc-201473B | 1 g 10 g 50 g | $69.00 $408.00 $1717.00 | 1 | |
Flunarizine provides indirect inhibition of Olfr51 by modulating calcium channels. Its action on voltage-gated calcium channels affects intracellular calcium levels, disrupting olfactory signal transduction and leading to the inhibition of Olfr51-mediated responses. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A acts as an indirect inhibitor by disrupting protein transport from the endoplasmic reticulum (ER) to the Golgi apparatus. Its interference with intracellular trafficking indirectly influences Olfr51 function, impacting olfactory signal transduction. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 inhibits calmodulin-dependent protein kinase II (CaMKII), providing indirect inhibition of Olfr51. Its action on CaMKII disrupts downstream signaling cascades, affecting olfactory signal transduction and leading to the inhibition of Olfr51-mediated responses. | ||||||